Giraldo-Cadavid Luis Fernando, Bastidas Alirio Rodrigo, Padilla-Ortiz Diana Marcela, Concha-Galan Diana Carolina, Bazurto María Angelica, Vargas Leslie
School of Medicine, Research Department, Universidad de La Sabana, Chia, Cundinamarca, Colombia.
Interventional Pulmonology Division, Fundacion Neumologica Colombiana, Bogota, Bogota DC, Colombia.
BMJ Open. 2017 Aug 21;7(8):e015235. doi: 10.1136/bmjopen-2016-015235.
Patients with obstructive sleep apnoea hypopnoea syndrome (OSA) might have varying degrees of laryngopharyngeal mechanical hyposensitivity that might impair the brain's capacity to prevent airway collapse during sleep. However, this knowledge about sensory compromises in OSA comes from studies performed using methods with little evidence of their validity. Hence, the purpose of this study is to assess the reliability and accuracy of the measurement of laryngopharyngeal mechanosensitivity in patients with OSA using a recently developed laryngopharyngeal endoscopic esthesiometer and rangefinder (LPEER).
The study will be prospective and double blinded, with a randomised crossover assignment of raters performing the sensory tests. Subjects will be recruited from patients with suspected OSA referred for baseline polysomnography to a university hospital sleep laboratory. Intra-rater and inter-rater reliability will be evaluated using the Bland-Altman's limits of agreement plot, the intraclass correlation coefficient, and the Pearson or Spearman correlation coefficient, depending on the distribution of the variables. Diagnostic accuracy will be evaluated plotting ROC curves using standard baseline polysomnography as a reference. The sensory threshold values for patients with mild, moderate and severe OSA will be determined and compared using ANOVA or the Kruskal-Wallis test, depending on the distribution of the variables. The LPEER could be a new tool for evaluating and monitoring laryngopharyngeal sensory impairment in patients with OSA. If it is shown to be valid, it could help to increase our understanding of the pathophysiological mechanisms of this condition and potentially help in finding new therapeutic interventions for OSA.
The protocol has been approved by the Institutional Review Board of Fundacion Neumologica Colombiana. The results will be disseminated through conference presentations and peer-reviewed publication.
This trial was registered at Clinical Trials Accuracy of the sensory test using the lLaryngopharyngeal endoscopic esthesiometer in obstructive sleep apnea. Protocol ID: 201611-22405. ClinicalTrials.gov ID: NCT03109171.
阻塞性睡眠呼吸暂停低通气综合征(OSA)患者可能存在不同程度的喉咽机械性感觉减退,这可能会损害大脑在睡眠期间预防气道塌陷的能力。然而,关于OSA患者感觉功能受损的这一认识来自于使用有效性证据不足的方法所进行的研究。因此,本研究的目的是使用一种最新开发的喉咽内镜感觉测量仪和测距仪(LPEER)来评估OSA患者喉咽机械感觉测量的可靠性和准确性。
本研究将是前瞻性和双盲的,由评估者进行随机交叉分配以执行感觉测试。研究对象将从因基线多导睡眠图检查而转诊至大学医院睡眠实验室的疑似OSA患者中招募。将根据变量的分布情况,使用布兰德 - 奥特曼一致性界限图、组内相关系数以及皮尔逊或斯皮尔曼相关系数来评估评估者内部和评估者之间的可靠性。将以标准基线多导睡眠图作为参考,通过绘制ROC曲线来评估诊断准确性。将根据变量的分布情况,使用方差分析或克鲁斯卡尔 - 沃利斯检验来确定并比较轻度、中度和重度OSA患者的感觉阈值。LPEER可能是评估和监测OSA患者喉咽感觉障碍的一种新工具。如果证明其有效,它可能有助于增进我们对该病症病理生理机制的理解,并有可能有助于找到针对OSA的新治疗干预措施。
该方案已获得哥伦比亚肺病基金会机构审查委员会的批准。研究结果将通过会议报告和同行评审出版物进行传播。
本试验已在ClinicalTrials.gov注册,试验名称为“使用喉咽内镜感觉测量仪对阻塞性睡眠呼吸暂停进行感觉测试的准确性”。方案编号:201611 - 22405。ClinicalTrials.gov标识符:NCT03109171。